Official UK procurement notice
Lymphdema and Complex Wounds - Barking and Dagenham, Havering and Redbridge (BHR)
Authority: NHS North East London Integrated Care Board (Central government)
What is being bought
Published requirement descriptionProvision of a Lymphedema and Complex Wound Care Service for residents of Barking and Dagenham, Havering and Redbridge. The service will deliver specialist assessment, diagnosis, treatment and ongoing management of patients with lymphedema and complex wounds in community settings. Care will be provided by appropriately trained registered nurses and Healthcare Assistants (HCAs), ensuring high-quality, patient-centred care and continuity of treatment.
CPV: Health services
The lotProcurement structure
single lot · no lot value publishedLot #1This procurement relates to the provision of a Lymphedema and Complex Wound Care…Awarded
This procurement relates to the provision of a Lymphedema and Complex Wound Care Service to the population of Barking & Dagenham, Havering and Redbridge.
The service will include, but is not limited to:
Comprehensive assessment and diagnosis of lymphedema
Development and implementation of individualised care plans
Delivery of specialist lymphedema treatments
Complex wound care assessment and management
Ongoing monitoring and review of patients
Patient education, prevention strategies and self-management support. Multidisciplinary working with other healthcare professionals Services will be delivered in community settings by suitably qualified and trained clinical staff, including registered nurses and HCAs. The service aims to improve patient outcomes, enhance quality of life, reduce complications and support patients to manage their conditions effectively.
This is a direct award; no competition.
Contract Value:
£649,912.72
Contract Duration:
01 May 2026 - 31 March 2027
Procurement Route:
This contract is intended to be awarded under the Provider Selection Regime (PSR) Direct Award Process C.
Rationale for Direct Award:
The current provider is delivering the service to a satisfactory standard. There are no proposed changes to the existing contract terms. Continuity of care is essential for this patient cohort
The provider meets all relevant clinical and service requirements
Decision:
The contracting authority intends to award the contract to the existing provider in line with PSR Direct Award C. Additional information: Procurement Route:
This contract is intended to be awarded under the Provider Selection Regime (PSR) Direct Award Process C.
Rationale for Direct Award:
The current provider is delivering the service to a satisfactory standard. There are no proposed changes to the existing contract terms. Continuity of care is essential for this patient cohort
The provider meets all relevant clinical and service requirements
Decision:
The contracting authority intends to award the contract to the existing provider in line with PSR Direct Award C.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Services
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 15 Apr 2026, 15:03 BST
- Last source update
- 15 Apr 2026, 15:03 BST
- Authority reference
BHR Complex Wound Care 325a- FTS notice number
2026/S 000-034303- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-06833cFind a Tender
- Why no open competition
- No tenders or no suitable tenders/requests to participate in response to open procedure
- Published justification
Procurement Route:
This contract is intended to be awarded under the Provider Selection Regime (PSR) Direct Award Process C.
Rationale for Direct Award:
The current provider is delivering the service to a satisfactory standard. There are no proposed changes to the existing contract terms. Continuity of care is essential for this patient cohort
The provider meets all relevant clinical and service requirements
Decision:
The contracting authority intends to award the contract to the existing provider in line with PSR Direct Award C.
- Review procedure
This contract is awarded under the Provider Selection Regime (PSR) Direct Award Process C.
The contracting authority is satisfied that the existing provider is delivering the service to a satisfactory standard, there are no material changes to the contract terms, and continuity of care is critical for patients accessing the service. Accordingly, the contract has been awarded to the current provider without competition.
This is a Provider Selection Regime (PSR) confirmation of contract award notice. This contract has been awarded under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The contract has now been formally awarded using Direct Award Process C.
The contract was awarded following completion of the standstill period in accordance with the PSR process. No representations were received / All representations received were reviewed and appropriately addressed prior to award (delete as applicable).
The contract has been awarded. The service will be provided from 01/05/2026 to 31/03/2027. The lifetime value of the contract is £649,912.72.
The provider was previously assessed at intention to award stage against the five key criteria using a scoring scale of 0-4 with the following weightings:
Quality and Innovation: 30%
Value for Money: 20%
Integration, Collaboration and Service Sustainability: 20%
Improving Access, Reducing Health Inequalities and Facilitating Choice: 20%
Social Value: 10%
The weighting methodology was applied consistently to reflect service priorities. Choice and equality requirements were prioritised due to the service supporting patient access and reducing inequalities, while Social Value was weighted lower as a developing requirement. The remaining criteria were evenly distributed across core service delivery priorities.
This assessment included evaluation across sub-categories reflecting both current and future performance.
The final award decision was made by NHS North East London Integrated Care Board, with Julian Buckton, Head of Planning and Programmes, Redbridge, as the designated decision-maker.
No conflicts of interest were declared by individuals involved in the decision-making process, and any potential conflicts were appropriately managed in accordance with governance procedures.
Publisher note: This procurement is being undertaken in accordance with the Health Care Services (Provider Selection Regime) Regulations 2023. The Contracting Authority has applied Direct Award Process C on the basis that the existing provider is currently delivering the service to a satisfactory standard and there are no material changes to the scope, specification, or terms and conditions of the contract. The Contracting Authority has assessed the existing provider against the key criteria set out in the Provider Selection Regime, including quality and innovation, value for money, integration, collaboration, and service sustainability. The assessment confirmed that the provider continues to meet the requirements and is capable of delivering the service effectively. The existing provider is delivering the current contract to a satisfactory standard and is expected to continue to deliver the proposed contract to an appropriate standard. The decision to award without competition is supported by the need to ensure continuity of care for patients requiring lymphedema and complex wound care services, where disruption could negatively impact patient outcomes. No conflicts of interest have been identified in relation to this decision. This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 do not apply to this award. Each of the five key criteria was reviewed and scored against current service delivery and potential service development. The provider was assessed on both scored and pass/fail criteria and met all requirements. The publication of this notice marks the start of the standstill period. Representations by providers must be made to the decision makers by Tuesday 28th April 2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. Written representations should be sent to: hub.psrprepresentation@nhs.net No conflicts of interest were identified in the decision-making process. The provider was assessed against the five key criteria using a scoring scale of 0-4, with percentage weightings applied based on the importance of each criterion to the service requirements: Quality and Innovation: 30% Value for Money: 20% Integration, Collaboration and Service Sustainability: 20% Improving Access, Reducing Health Inequalities and Facilitating Choice: 20% Social Value: 10% The criteria were applied with their respective weightings, with scoring undertaken across a range of sub-categories. An assessment of both current and future performance against these sub-categories was completed. The publication of this notice marks the start of the standstill period, commencing on 17 April 2026 and ending at 23:59 on Tuesday 28 April 2026. The contract may be formally awarded on Tuesday 28 April 2026, provided no representations are received, or once any representations have been addressed. Representations by providers must be submitted by 23:59 on Tuesday 28 April 2026 to: hub.psrrepresentation@nhs.net This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Accelerate CIC Joseph's Hospice | £649,913 † | — | Awarded |
Contracts
Contract 034303-2026-1 · Accelerate CIC Joseph's Hospice
- Signed
- 15 Apr 2026
- Value
- £649,913
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- NHS North East London Integrated Care BoardReview body
Bidders & participating suppliers
1 commercial party on the notice- Accelerate CIC, Joseph's HospiceAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.